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Abstract
Background: Radial artery occlusion (RAO) is an infrequent complication of transradial 
coronary procedures (TRA). To our knowledge, there is no satisfactory data regarding the late 
term incidence and predictors of RAO in the literature. Our aim was to establish the long-term 
incidence of radial artery occlusion and investigate its predictors.
Methods: This was a single center prospective study. A total number of 409 consecutive 
patients undergoing their first TRA were recruited. Clinical and procedural data were all 
recorded. Doppler ultrasound examination was performed at 6–15 months following the in-
tervention.
Results: RAO was detected in 67 patients and 342 patients maintained radial artery patency. 
The overall RAO incidence was 16.4% at late term. Patients with RAO were younger than the 
patients with patent radial arteries (55.9 ± 9.7 vs. 59.1 ± 9.4 years, p = 0.014). The incidence 
of RAO in hypertensive patients (9.8%) was lower (p < 0.001) than the observed incidence 
(23%) in non-hypertensive patients. RAO group had higher rate (28%, p = 0.027) of post-
-procedural access site pain. Regression analysis revealed that hypertension was negative while 
post-procedural access site pain was positive independent predictors for RAO. In addition, the 
relative risk for RAO also increased significantly (p < 0.001) when the ratio of sheath/artery 
diameter (S/A) was > 1.
Conclusions: The present study reveals that the long-term incidence of RAO is 16.4%. Hy-
pertension, post-procedural access site pain and S/A ratio > 1 are independent predictors of 
RAO at late term. (Cardiol J 2014; 21, 4: 350–356)
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Introduction
Radial artery occlusion (RAO) is a complication 
of transradial coronary procedures (TRA) which can 
lead to permanent occlusion of the radial artery. 
This complication is not benign, as hand ischemia, 
resulting from RAO, has been reported [1, 2]. 
Furthermore, once the artery is occluded, it cannot 
be used as an access site for future catheterizations 
or as an arterial conduit for bypass surgery.
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In the literature, the reported RAO incidence 
of patients undergoing TRA varies from 1% to 10% 
[3–5]. In all these studies, RAO was evaluated in 
the early period (up to 1 month) follow-up. How - 
ever, spontaneous recanalization of the radial arte-
ry was as long as 3 months after decannulation [6]. 
The underlying mechanism of occlusion in the early 
period is the presence of radial artery thrombus. 
Data on the long-term course of patients with RAO 
are limited. In a study conducted by Nagai et al. [5], 
the total incidence of RAO at the end of 3-month 
follow-up was 5%. Chronic phase vascular compli-
cations such as diffuse stenosis and loss of forward 
flow occur at a period of 1 to 6 months following 
the procedure [5]. However, there is no report 
regarding the incidence of RAO after a follow-up 
period of 6 months following TRA. Therefore, our 
aim was to investigate the long-term incidence of 
RAO and to find out its predictors.
Methods
Patient population
This was a single center prospective study. 
After applying the exclusion criteria, a total number 
of 409 consecutive patients undergoing their first 
transradial coronary angiography were recruited 
from May to October 2010. Patients with previous 
transradial procedure (n = 15) and abnormal Allen 
test (n = 10) were excluded. Procedures were 
performed by 2 experienced high-volume radial 
operators (with a personal experience of > 1000 
cases). All of these patients gave written informed 
consent and the study was approved by the ethics 
committee of Acıbadem University School of 
Medicine.
Radial artery cannulation, retrograde  
radial arteriography and  
subclavian arteriography
After local subcutaneous anesthesia with 1% 
lidocaine, radial artery puncture was performed 
with a dedicated radial cannulation needle and gu-
ide wire. A hydrophilic 5 F or 6 F sheath (Terumo, 
Japan) was used to complete arterial puncture, then 
500 µg glycerol trinitrate and 2.5 mg verapamil 
were injected into radial artery along the sheath. 
Heparin 5,000 IU was given in the aortic root. 
Retrograde radial arteriography was performed as 
previously described [7]. If the operator encoun-
tered serious problems, which meant the need for 
a hydrophilic guide wire, or difficulty in engaging 
the coronary ostia with an exaggerated S-shape 
configuration of the catheter or wire, during cros-
sing the subclavian-aortic truncus, retrograde 
subclavian arteriography was also performed.
Transradial coronary procedure
For coronary angiography and intervention, 
the catheters to be employed were 5 F or 6 F size 
catheters. If the patient needed revascularization 
after angiography, the procedure was completed 
with an ad hoc percutaneous coronary intervention. 
In these patients, an additional bolus of 5,000 IU 
heparin was administered. Once the introducer was 
withdrawn immediately after the procedure, hemo-
stasis was achieved by means of manual compres-
sion and pressure dressing, which was performed 
by a registered and trained nurse. Patients were 
allowed to walk around immediately after the end 
of the procedure. All the patients were discharged 
on the third hour after TRA.
Classification and definitions
Anomalies of the upper limb arteries were 
recorded and defined as previously described [7]. 
Brachial and subclavian artery tortuosity was 
defined as angulation of the artery more than 90°.
Procedure success was defined as coronary 
angiography completed with the initial radial artery 
approach without changing to another route.
Sheath removal time (minutes) was defined 
as the time interval between the insertion of the 
sheath and its removal.
Any stenosis in the radial artery greater than 
25% at the distal of the puncture needle or sheath 
was defined as radial artery spasm (RAS) [8]. RAS 
was diagnosed by at least 2 experienced operators. 
After radial arteriography, off-line quantitative 
analysis was used to determine the percentage of 
stenosis.
Post-procedural pain was characterized as ac-
cess site or forearm pain following compression and 
hemostasis with or without swelling in any time 
between in-hospital and out-hospital follow-up.
Major vascular complications were defined 
as vascular access complications which required 
surgical or radiological intervention, hematoma 
> 5 cm, red cell transfusion at the discretion of 
the treating physician or which led to a drop in he-
moglobin level of more than 3 g/dL, limb ischemia 
and/or compartment syndrome.
Minor vascular complications were defined as 
vessel dissection and rupture without leading to 
ischemia, hematoma less than 5 cm, pseudo-aneu-
rysm, arteriovenous fistulae and localized infection.
352 www.cardiologyjournal.org
Cardiology Journal 2014, Vol. 21, No. 4
Doppler ultrasound measurements
RAO was assessed by ultrasound examination 
at least 6 months (average 11.3 ± 1.5 month) after 
the procedure. All sonographic examinations were 
performed by 2 experienced radiologists, who had 
no knowledge of the catheterization procedure, 
using a Siemens (Acuson, Antares Premium edition 
US System, Siemens, Munich, Germany) ultraso-
und machine with a multifrequency linear probe. 
Subject’s right and left forearms were in supination 
with a pillow placed under wrists. The probe was 
placed on the ventral wrist to parallel the long axis 
of the forearm, using the color mode to localize the 
radial artery. The measurements were collected 
at the segment 5 mm distal to the radial styloid 
process. The luminal diameter of the radial artery 
was assessed by superimposing 2-dimensional 
sonography to the comparative image of the color 
Doppler. The radial flow was assessed by Doppler 
measurement, and flow was graded from 0 to 3 as 
previously described [9]. RAO was defined as the 
presence of grade 0–1 flow on Doppler examination.
Ratio of sheath size to radial artery diameter 
(S/A) was estimated by dividing the value of 
the observed radial artery luminal diameter (in 
milimeters) to 1.65 for 5 F sheaths and to 1.98 for 
6 F sheaths.
Data collection
Demographic and clinical characteristics of 
the patients were recorded. Total procedure and 
fluoroscopy time (in minutes), amount of contrast 
used (in milliliters), sheath size (5 F or 6 F), sheath 
removal time (in minutes), access site (right or left 
radial artery), heparin dose (5,000 or 10,000 IU), 
peri-procedural RAS, peri-procedural radial artery 
rupture, and presence of post-procedural access 
site pain were also recorded. Radial artery Doppler 
findings as radial artery diameter and flow were 
also registered.
Statistical analysis
All analyses were performed using SigmaPlot 
11.0 statistical software (Systat Software Inc., San 
Jose, California). Continuous data were summarized 
as mean ± standard deviation. Categorical variables 
were expressed as absolute values and percentages. 
Multiple logistic linear regression analysis was 
performed to identify independent predictors of 
RAO. Continuous variables were compared using 
Student’s t test and Mann-Whitney U test, as appro-
priate. Differences between categorical variables 
were examined using the c2 test. P values of < 0.05 
were considered statistically significant.
Results
Demographic and clinical characteristics  
of study population
Study population consisted of 409 patients 
with mean age 58.5 ± 9.4 years, 67% male. Doppler 
ultrasonography was performed to study patients 
at 6 to 15 months after a TRA. The mean follow up 
period was 11.3 ± 1.5 months prospectively. The 
RAO was observed in 67 patients (16.4% of the stu-
dy population). Table 1 summarizes demographic 
and clinical characteristics of the study population.
Demographic and clinical characteristics  
of study groups
The patients were divided into two groups 
according to the patency of radial artery estimated 
by late Doppler ultrasound examination; patent 
radial artery (RAP group) and occluded radial 
artery group (RAO group). Table 2 summarizes 
demographic and clinical characteristics of these 
two groups of patients. Prevalence of diabetes mel-
litus in both groups was similar (Table 2), while the 
prevalence of hypertension was significantly lower 
in the RAO group (hypertension rates; RAP 54% 
vs. RAO 30%, p < 0.001).
Procedural and Doppler data  
in RAP and RAO groups
Table 3 summarizes the procedural and 
Doppler data for RAP and RAO groups. The pro-
Table 1. Demographics and clinical characteri-
stics of the study population. 
Age [year] 58.5 ± 9.4
Body weight [kg] 81.4 ± 14.3
Height [cm] 168 ± 8
Body mass index [kg/m2] 28.9 ± 5.0
Male 276 (67.5%)
Female 133 (32.5%)
Risk factors:
Hypertension 203 (49.6%)
Diabetes 103 (25.2%)
Smoking 131 (32.0%)
Clinical presentations
Stabile angina 289 (70.7%)
ACS 110 (26.9%)
History of CABG 12 (2.4%)
DUT [months] 11.3 ± 1.5
Radial artery occlusion 67 (16.4%)
ACS — acute coronary syndrome; CABG — coronary artery bypass 
grafting; DUT — Doppler ultrasonography time
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Table 2. Demographic and clinical characteristics of the study groups.  
Study groups P
RAP (n = 342) RAO (n = 67)
Age [year] 59.1 ± 9.4 55.9 ± 9.7 0.014*
Male gender 233 (68%) 43 (64%) NS
Height [cm] 168.1 ± 7.4 166.9 ± 8.2 NS
Weight [kg] 81.5 ± 14.3 80.6 ± 14.7 NS
Body mass index [kg/m2] 28.9 ± 4.9 28.9 ± 5.5 NS
Diabetes mellitus 89 (26%) 14 (21%) NS
Hypertension 183 (54%) 20 (30%) < 0.001*
Smoking 104 (30%) 27 (40%) NS
History of CABG 11 (3%) 1 (1%) NS
Stable angina 245 (71%) 44 (65%) NS
Acute coronary syndrome 90 (26%) 20 (29%) NS
Fasting glucose [mg/dL] 129.8 ± 60.9 125.4 ± 59.1 NS
Creatinine [mg/dL] 0.85 ± 0.22 0.85 ± 0.20 NS
Total cholesterol [mg/dL] 197.6 ± 49.1 185.7 ± 62.7 NS
Triglycerides [mg/dL] 161.84 ± 68.2 144.25 ± 64.3 NS
Aspirin 172 (50%) 33 (49%) NS
Clopidogrel 7 (2%) 1 (1%) NS
Aspirin + clopidogrel 41 (12%) 11 (16%) NS
Warfarin 12 (3%) 2 (2%) NS
*Statistically significant value; CABG — coronary artery bypass grefting; NS — non-significant; RAP — patent radial artery; RAO — radial arte-
ry occlusion
Table 3. Procedural and Doppler data of the patients.
Study groups P
RAP (n = 342) RAO (n = 67)
Procedure time [min] 7.8  ± 3.6 8.4 ± 3.8 0.260
Fluoroscopy time [min] 2.8 ± 2.1 2.97 ± 1.8 0.471
Amount of contrast [mL] 58.9  ± 20.5 57.1 ± 17.3 0.482
Dose area product [Gy*cm2] 2153 ± 1372 1883 ± 929 0.126
Sheath size:
5 French sheath 152 (45%) 31 (46%) 0.920
6 French sheath 190 (55%) 36 (54%)
Number of catheters used 2.0 ± 0.26 2.0 ± 0.21 0.644
Number of guidewires used 1.17 ± 0.44 1.18 ± 0.42 0.713
Sheath removal time [min] 32.30 ± 17.1 30.33 ± 13.0 0.952
Right radial access 192 (56%) 35 (52%) 0.650
Number of PCI 77 (22%) 10 (15%) 0.221
Heparin dose:
5,000 IU 322 (94%) 63 (94%) 0.806
10,000 IU 18 (5%) 4 (5%) 0.943
Radial artery spasm 24 (7%) 8 (12%) 0.261
Rupture 2 (0.5%) 0 (0%) 0.741
Post-procedural pain 55 (16%) 19 (28%) 0.027*
Total vascular anomalies# 77 (22%) 11 (16%) 0.664
Radial artery diameter [mm] 2.30 ± 0.40 1.80 ± 0.51 < 0.001*
S/A ratio 0.84 ± 0.19 1.12 ± 0.38 < 0.001*
S/A ratio > 1 45 (13%) 46 (69%) < 0.001*
*Statistically significant; #includes radial loop, high bifurcation, tortuosity of radial, brachial and axillary arteries and remnant radial artery. 
High radial bifurcation (n = 39, 9%) and subclavian tortuosity (n = 28, 7%) were the two most common vascular anomalies; IU — International 
unit; PCI — percutaneous coronary intervention; RAP — patent radial artery; RAO — radial artery occlusion; S/A ratio — ratio of sheath size to 
estimated radial artery diameter
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cedure time, fluoroscopy time, used amount of 
contrast, dose area product, number of catheters 
and guide wires used were similar in both groups 
(Table 3). There was no difference regarding the 
use of 5 F and 6 F sheaths and sheath removal ti-
mes between the groups. Heparin doses (5,000 or 
10,000 IU) and number of percutaneous coronary 
intervention performed were also not significantly 
different between the two groups (Table 3).
Doppler ultrasound examination revealed that 
the radial artery diameter in the RAO group was 
(1.8 ± 0.5 mm) significantly (p < 0.001) narrower 
than the observed value (2.3 ± 0.4 mm) for the 
RAP group. The radial artery diameter was po-
sitively correlated with body weight (r = 0.254, 
p < 0.001), height (r = 0.211, p < 0.001) and body 
mass index (r = 0.144, p < 0.01).
Predictors of RAO
The RAO group was younger than the RAP 
group (Table 2). The incidence of RAO was lower 
in hypertensive patients (RAP group 54% vs. RAO 
group 30%, p < 0.001) and higher in patients with 
post-procedural access site pain (RAP group 16% 
vs. RAO group 28%, p = 0.027). S/A ratio in RAO 
group was (1.12 ± 0.38) significantly (p < 0.001) 
higher than the observed value (0.84 ± 0.19) for 
the RAP group. In addition, the rate of patients 
with S/A ratio > 1 in the RAO group was 69%, 
significantly (p < 0.001) higher than the estimated 
value (13%) for the RAP group.
Multiple logistic regression analysis revealed 
that presence of hypertension was an independent 
strong negative predictor (p < 0.001) of RAO. The 
relative risk for RAO decreased to 0.432 (95% CI 
0.266–0.702) in the presence of hypertension. 
Likewise, multiple logistic regression analysis 
revealed that post-procedural access site pain was 
also a significant (p = 0.027) predictor for RAO. 
The relative risk for RAO in presence of the post-
-procedural access site pain increased to 1.792 
(95% CI 1.122–2.861). When S/A ratio were > 1, 
the relative risk for RAO increased significantly to 
5.764 (95% CI 3.390–9.800).
Discussion
The present study established a higher inci-
dence of RAO (16.4%) compared with previously 
declared literature [3–5]. This discrepancy is un-
derstandable from our point of view as our study 
differs in two ways from other reports.
Firstly, to our knowledge this study is the first 
in terms of investigating the RAO incidence in the 
long-term with an average of 11.2 ± 1.5 months 
follow up after the procedure. In other words, the 
concerned incidence of RAO seems to represent 
the complication rates of both acute and chronic 
injuries. As the present study did not provide 
serial observations of the radial artery used for 
TRA, it is troublesome to define precisely which 
mechanism was mostly involved in our 16% RAO 
rate. Recently, Yonetsu et al. [10] demonstrated 
a smaller lumen diameter and increased intimal 
thickening of the radial artery at a mean period of 
11 months after the first trans-radial procedure in 
patients who have underwent repeated TRA. In 
a study by Nagai et al. [5], the incidence of RAO was 
found to be 5% by evaluation of the radial artery at 
95 ± 29 days following the procedure. This short 
period of follow up equals with the ongoing process 
of both remodeling and intimal thickening [11, 12]. 
Likewise, chronic phase vascular complications 
such as diffuse stenosis and loss of forward flow 
may mimic the same physiopathology of resteno-
sis related to angioplasty [13, 14]. Therefore, one 
might argue whether it is reasonable to expect 
a higher incidence of RAO at a longer follow-up 
(at least 6 months).
Secondly, RAO was diagnosed in all patients 
by ultrasonographic examination in contrast to 
previous studies in which diagnosis was made by 
absence of pulse [3, 15–17]. False positive pulses 
may result in underestimation of the incidence of 
RAO [5]. Thus, the diagnosis of RAO should be 
confirmed using a more objective technique such 
as duplex ultrasonography, which was lacking or 
was not included in all patients in most of the 
studies [18].
Several studies examining the rates of RAO 
have used multivariable models to identify inde-
pendent predictors of RAO. The following factors 
have been identified as independent predictors in 
the majority of studies: the diameter of the sheath 
and its relationship to the size of the radial artery, 
post-procedure compression time and the presence 
of antegrade flow in the artery during hemostasis, 
and the use of anticoagulation [4, 5, 19–21]. Except 
the sheath-to artery ratio, none of the remaining 
predictors determined the development of RAO 
in our study. The physiopathology of early RAO 
is related to thrombus formation [22] and the 
above mentioned predictors make sense in the 
early period of RAO. However, the predictors of 
RAO in the long-term period were found to be the 
sheath-to artery ratio > 1 (p < 0.001), absence of 
hypertension (p < 0.001) and post-procedural pain 
(p = 0.027) in our study.
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Severe flow reduction was found in patients with 
a sheath-to-artery ratio (S/A ratio) > 1 [9]. Others 
have made similar observations [5, 20]. Likewise, 
the concerned ratio was an independent predictor of 
long-term RAO in our study (p < 0.001). As we know, 
the inner luminal diameter of the radial artery decre-
ases after TRA at late term [23], the rational cause 
responsible for this undesirable complication might 
be the extensive structural damage caused by sheath 
insertion which in turn triggers for the events of 
intimal hyperplasia and vascular remodeling [11, 24].
Gwon et al. [25] indicated that an S/A ratio > 1 
is associated with pain during sheath insertion and 
removal. Post-procedural pain, which was found as 
an independent predictor of radial artery patency 
in our study, may be a clue of extensive structural 
damage triggering the cascade of events resulting 
in hyperplasia, remodeling, and finally occlusion.
The mechanism of hypertension being a pre-
dictor of the long-term patency of the radial artery 
remains elusive. We speculate that hypertension 
produces a steeper increase in radial artery flow, 
hence, reopening the occlusion in the early period 
and maintain vessel patency in the long-term conse-
quently. Another speculation might be that the arte-
rial stiffness in hypertension may preclude the total 
interruption of flow during manual compression, 
thus providing adequate maintenance of perfusion. 
In other words, patent hemostasis, which has been 
shown to decrease the rate of RAO [26, 27], might 
be the mechanism in our hypertensive patients.
Limitations of the study
The present study has several limitations. 
Hemostasis of radial artery access site was achie-
ved by manual compression and pressure dressing 
which may affect patent hemostasis. Another issue 
is that Doppler ultrasound imagination was not 
performed just before discharge to evaluate acute 
occlusion but this could be the subject of a further 
study to compare early and late term radiologic 
findings of the vessel following TRA.
Conclusions
The present study reveals that the long-term in-
cidence of RAO is 16.4%. S/A ratio > 1, hypertension 
and post-procedural access site pain are independent 
predictors of RAO at late term.
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